Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Diisopropylcarbodiimide → 4-[[N-(3-bromo-4-methylbenzoyl)glycyl]aminomethyl]-1-(4-chlorobenzyl)piperidine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Diisopropylcarbodiimide | HCID 12734 | — |
| 반응물 | 1-Hydroxybenzotriazole | HCID 75771 | — |
| 반응물 | 3-Bromo-4-methylbenzoic acid | HCID 82130 | — |
| 반응물 | 1-(4-Chlorobenzyl)-4-((glycylamino)methyl}piperidine | HCID 18426155 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 용매 | tert-Butanol | HCID 6386 | — |
| 생성물 | 4-[[N-(3-bromo-4-methylbenzoyl)glycyl]aminomethyl]-1-(4-chlorobenzyl)piperidine | HCID 18426237 | — |
반응 단계
A solution of 1-(4-chlorobenzyl)-4-{(glycylamino)methyl)piperidine (0.050 mmol) in CHCl3 (1.35 mL) and tert-butanol (0.15 mL) was treated with 3-bromo-4-methylbenzoic acid (0.060 mmol), diisopropylcarbodiimide (0.060 mmol), and HOBt (0.060 mmol). The reaction mixture was stirred at room temperature for 15 h. The mixture was loaded onto Varian™ SCX column, and washed with CH3OH/CHCl3 1:1 (12 mL) and CH3OH (12 mL). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated to afford 4-[{N-(3-bromo-4-methylbenzoyl)glycyl}aminomethyl]-1-(4-chlorobenzyl)piperidine (Compound No. 1113) (16.1 mg, 65%): The purity was determined by RPLC/MS (95%); ESI/MS m/e 494.0 (C23H27BrClN3O2).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06451842B1 |
| 출처 데이터셋 | uspto-grants-2002_09 |
| ORD ID | ord-9ed96c40a20c423e96ea478b1b68b1e3 |
| 출처 메모 | uspto-grants-2002_09 |